Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism. Learn more.

Findings seen over three months in men with low-grade prostate cancer, hypogonadism treated with radical prostatectomy.

In a randomized clinical trial, Mass General Brigham researchers found testosterone replacement therapy also improved quality of life for men who had undergone radical prostatectomy ...

Low-intensity extracorporeal shock wave therapy (LI-SWT) did not improve erectile dysfunction compared to a sham procedure in radical prostatectomy patients. Fewer than 20% of men in the LI-SWT group ...

The SPIRIT randomized trial provides level 1 data supporting short-term testosterone therapy to manage hypogonadal men with low grade, localized prostate cancer after radical prostatectomy.

Stereotactic body radiotherapy as salvage therapy after radical prostatectomy was well tolerated. Toxic effects were comparable to a historical cohort of patients receiving conventionally fractionated ...

A meta-analysis involving more than 6000 men suggested that adding hormone therapy (HT) to radiation after radical prostatectomy improves overall survival (OS) in those with higher pre-radiation ...

Perioperative outcomes from a randomized controlled trial comparing MRI-guided transurethral ultrasound ablation (TULSA) to robot-assisted radical prostatectomy (RARP). Efficacy, safety, and ...

Every year, hundreds of thousands of men receive a prostate cancer diagnosis and immediately face a decision that medical ...

A prostatectomy is surgery to partially or completely remove the prostate gland to treat conditions such as prostate cancer or benign prostatic hyperplasia (BPH). A radical prostatectomy is the ...